Krishna Institute of Medical Sciences Limited
Simbol: KIMS.BO
BSE
1965.3
INRTržna cena danes
47.3931
Razmerje P/E
2.1584
Razmerje PEG
157.28B
Kapaciteta MRK
- 0.00%
Donos DIV
Krishna Institute of Medical Sciences Limited (KIMS-BO) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1706.5 | 1899.9 | 2842.5 | ||||||||
balance-sheet.row.short-term-investments | 0 | 1090.4 | 1643.5 | 2321.2 | ||||||||
balance-sheet.row.net-receivables | 0 | 2718.9 | 1479.4 | 1373.8 | ||||||||
balance-sheet.row.inventory | 0 | 428.6 | 364.3 | 240.8 | ||||||||
balance-sheet.row.other-current-assets | 0 | 114.7 | 101.7 | 27.3 | ||||||||
balance-sheet.row.total-current-assets | 0 | 4776.4 | 3934 | 4511.9 | ||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 18575.1 | 9094.3 | 8308 | ||||||||
balance-sheet.row.goodwill | 0 | 3080.1 | 847.8 | 847.8 | ||||||||
balance-sheet.row.intangible-assets | 0 | 777.4 | 317.6 | 247.4 | ||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 3857.4 | 1165.3 | 1095.2 | ||||||||
balance-sheet.row.long-term-investments | 0 | 61.7 | 3338.1 | 192.2 | ||||||||
balance-sheet.row.tax-assets | 0 | 401.9 | 32.1 | 29.4 | ||||||||
balance-sheet.row.other-non-current-assets | 0 | 1740.5 | 1509.6 | 224.8 | ||||||||
balance-sheet.row.total-non-current-assets | 0 | 24636.7 | 15139.5 | 9849.6 | ||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-assets | 0 | 29413 | 19073.5 | 14361.5 | ||||||||
balance-sheet.row.account-payables | 0 | 1742.5 | 1295.3 | 1318.7 | ||||||||
balance-sheet.row.short-term-debt | 0 | 445.8 | 302.1 | 884.3 | ||||||||
balance-sheet.row.tax-payables | 0 | 0 | 1.7 | 87 | ||||||||
balance-sheet.row.long-term-debt-total | 0 | 6335.9 | 2263.2 | 2279.4 | ||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 12.4 | ||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||
balance-sheet.row.other-current-liab | 0 | 606.7 | 417.5 | 442.1 | ||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 7068.7 | 2817 | 2816.3 | ||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.capital-lease-obligations | 0 | 1449.6 | 955 | 459 | ||||||||
balance-sheet.row.total-liab | 0 | 10033.4 | 4967.1 | 5599.6 | ||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.common-stock | 0 | 800.3 | 800.3 | 775.9 | ||||||||
balance-sheet.row.retained-earnings | 0 | 5382.8 | 2674.8 | -644.3 | ||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 11140.6 | 11140.6 | 9224 | ||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -628.4 | -742.6 | -718.3 | ||||||||
balance-sheet.row.total-stockholders-equity | 0 | 16695.4 | 13873.1 | 8637.3 | ||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 29413 | 19073.5 | 14361.5 | ||||||||
balance-sheet.row.minority-interest | 0 | 2684.2 | 233.3 | 124.6 | ||||||||
balance-sheet.row.total-equity | 0 | 19379.6 | 14106.4 | 8762 | ||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||
Total Investments | 0 | 566.9 | 3331.7 | 24.3 | ||||||||
balance-sheet.row.total-debt | 0 | 6781.7 | 2565.3 | 3163.7 | ||||||||
balance-sheet.row.net-debt | 0 | 6165.6 | 2308.9 | 2642.4 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 4849.1 | 4568.5 | 2790.2 | ||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1292.6 | 726.7 | 695.4 | ||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.change-in-working-capital | 0 | -692.8 | -744.7 | 141.5 | ||||||||
cash-flows.row.account-receivables | 0 | -628.1 | -232.7 | 177.5 | ||||||||
cash-flows.row.inventory | 0 | 64.7 | -123.4 | 62.9 | ||||||||
cash-flows.row.account-payables | 0 | -410.8 | 101.2 | 239.2 | ||||||||
cash-flows.row.other-working-capital | 0 | 281.4 | -489.7 | -338.1 | ||||||||
cash-flows.row.other-non-cash-items | 0 | -1128 | -1310.3 | -67.3 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -5745.3 | -1703.2 | -944.3 | ||||||||
cash-flows.row.acquisitions-net | 0 | -2161.9 | -3240.9 | -352.7 | ||||||||
cash-flows.row.purchases-of-investments | 0 | -5392.8 | -5828.1 | -2409.6 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 7010.4 | 6520 | 113.8 | ||||||||
cash-flows.row.other-investing-activites | 0 | 133.6 | 137 | 51 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -6155.9 | -4115.2 | -3541.8 | ||||||||
cash-flows.row.debt-repayment | 0 | -2410.8 | -2334.4 | -1300.4 | ||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 1916.6 | 950.2 | ||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.other-financing-activites | 0 | 3294.2 | 1027.8 | 448.4 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 883.4 | 610 | 98.2 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 1311.4 | 0 | 0 | ||||||||
cash-flows.row.net-change-in-cash | 0 | 359.8 | -264.9 | 116.2 | ||||||||
cash-flows.row.cash-at-end-of-period | 0 | 616.1 | 256.3 | 521.3 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 256.3 | 521.3 | 405.1 | ||||||||
cash-flows.row.operating-cash-flow | 0 | 4320.9 | 3240.3 | 3559.7 | ||||||||
cash-flows.row.capital-expenditure | 0 | -5745.3 | -1703.2 | -944.3 | ||||||||
cash-flows.row.free-cash-flow | 0 | -1424.3 | 1537 | 2615.5 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 21976.8 | 16508.3 | 13122.1 | ||||||||
income-statement-row.row.cost-of-revenue | 0 | 8270.8 | 6170.6 | 4931.1 | ||||||||
income-statement-row.row.gross-profit | 0 | 13706 | 10337.6 | 8191 | ||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.other-expenses | 0 | 258.7 | 202.6 | 36.1 | ||||||||
income-statement-row.row.operating-expenses | 0 | 8958.4 | 5906.5 | 5063.8 | ||||||||
income-statement-row.row.cost-and-expenses | 0 | 17229.3 | 12077.1 | 9995 | ||||||||
income-statement-row.row.interest-income | 0 | 61.1 | 122.8 | 58 | ||||||||
income-statement-row.row.interest-expense | 0 | 305.4 | 160.3 | 293.1 | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -99.5 | -198.2 | -381.9 | ||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||
income-statement-row.row.other-operating-expenses | 0 | 258.7 | 202.6 | 36.1 | ||||||||
income-statement-row.row.total-operating-expenses | 0 | -99.5 | -198.2 | -381.9 | ||||||||
income-statement-row.row.interest-expense | 0 | 305.4 | 160.3 | 293.1 | ||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1292.6 | 726.7 | 695.4 | ||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||
income-statement-row.row.operating-income | 0 | 4887.5 | 4558.7 | 3134 | ||||||||
income-statement-row.row.income-before-tax | 0 | 4849.1 | 4568.5 | 2790.2 | ||||||||
income-statement-row.row.income-tax-expense | 0 | 1190.9 | 1130.6 | 735.4 | ||||||||
income-statement-row.row.net-income | 0 | 3363.2 | 3326.8 | 2012.2 |
Pogosto zastavljeno vprašanje
Kaj je Krishna Institute of Medical Sciences Limited (KIMS.BO) skupna sredstva?
Krishna Institute of Medical Sciences Limited (KIMS.BO) skupna sredstva so 29413030000.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so N/A.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.621.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 42.228.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 0.138.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.209.
Kaj je Krishna Institute of Medical Sciences Limited (KIMS.BO) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je 3363220000.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 6781740000.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 8958440000.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 0.000.